AHNAK2 and neoplasm: Consistently, AHNAK2, a protein which was previously proposed as a PDAC prognosis marker with unknown function35,36, was positive in tumor area of 25/28 patients, compared with only 1/28 patients positive at adjacent normal area (X-squared = 37.979, degree of freedom = 1, p value = 7.1 × 10−10).